Your session is about to expire
← Back to Search
Antifibrinolytic
Tranexamic Acid for Broken Bones
N/A
Waitlist Available
Led By Dirk W Kiner, MD
Research Sponsored by University of Tennessee
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through postoperative day four
Awards & highlights
Study Summary
Tranexamic acid is an antifibrinolytic drug that has been used to decrease post-operative blood loss. This study is a prospective, randomized controlled trial investigating the use of tranexamic acid in fracture surgery around the hip and knee, in which significant blood loss (>300mL) is expected. The hypothesis of this study is that tranexamic acid will be associated with a decrease in post-operative blood loss, as well as a decreased need for allogenic blood transfusion, in patients who have fracture surgery around the hip and knee.
Eligible Conditions
- Blood Loss
- Trauma
- Broken Bones
- Surgery
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through postoperative day four
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through postoperative day four
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
hemoglobin value
Secondary outcome measures
hematocrit value
number of units of allogenic blood transfused
Side effects data
From 2015 Phase 4 trial • 29 Patients • NCT020630358%
Postoperative wound infection
8%
Postoperative wound infection after release from hospital
8%
Myocardial infaction
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Tranexamic Acid
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Tranexamic AcidExperimental Treatment1 Intervention
15 mg/kg preoperative IV dose followed by another 15 mg/kg IV dose three hours after the initial dose
Group II: ControlActive Control1 Intervention
No tranexamic acid given
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tranexamic acid
FDA approved
Find a Location
Who is running the clinical trial?
University of TennesseeLead Sponsor
189 Previous Clinical Trials
141,928 Total Patients Enrolled
Dirk W Kiner, MDPrincipal InvestigatorUTCOM Chattanooga / Erlanger Health System
1 Previous Clinical Trials
11 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger